Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Ferric Carboxymaltose in Children With IBD-Related Anemia
2012-005644-26Phase 4Active
- Sponsor
- Atrium Medical Corporation
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in anaemia, inflammatory bowel disease (IBD), Crohn's disease, autoimmune colitis, sponsored by Atrium Medical Corporation. Started Jul 2013; status: active.
02
Drugs
ferric carboxymaltose
03
Conditions
anaemiainflammatory bowel disease (IBD)Crohn's diseaseautoimmune colitis
Beyond the preview
Go deeper on 2012-005644-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005644-26.